SEVELAMER WAYMADE (Waymade Australia Pty Limited)
Product name
SEVELAMER WAYMADE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
127 (255 working days)
Active ingredients
Sevelamer hydrochloride
Registration type
New generic medicine
Indication
Sevelamer Waymade is indicated for the management of hyperphosphataemia in adult patients with stage 4 and 5 chronic kidney disease.